Emerging Cannabinoid Compounds Show Potential as Anticancer Agents in Multiple Myeloma Research
The burgeoning field of cannabinoid research continues to unveil the therapeutic value of compounds traditionally overshadowed by the more widely studied tetrahydrocannabinol (THC) and cannabidiol (CBD). A recent study published in the journal BioFactors introduces a compelling narrative surrounding the potential anticancer properties of lesser-known cannabinoids, particularly in the context of multiple myeloma (MM), a hematological malignancy characterized by the …